Cellular therapy: changing clinical practice for treatment of myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:28 3 years ago 79 Далее Скачать
Is there an optimal time to deploy immunotherapies in multiple myeloma? Multiple Myeloma Hub 3:54 4 years ago 97 Далее Скачать
Is treatment discontinuation feasible for patients with myeloma with deep and durable responses? VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 82 Далее Скачать
Q&A | Next wave of immune-based therapies in R/R MM Multiple Myeloma Hub 5:00 3 months ago 91 Далее Скачать
What non-cellular immunotherapies are in development for multiple myeloma? Multiple Myeloma Hub 3:07 4 years ago 153 Далее Скачать
Defining and identifying ultra-high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:11 10 months ago 448 Далее Скачать
Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma Multiple Myeloma Hub 23:53 4 months ago 521 Далее Скачать
Access and future prospects of advanced immunotherapies for multiple myeloma in Europe Multiple Myeloma Hub 7:50 2 years ago 120 Далее Скачать
What are the most promising CAR T therapies in development for multiple myeloma? Multiple Myeloma Hub 4:11 5 years ago 452 Далее Скачать
What are the main improvements in next-generation CAR T-cell products? Multiple Myeloma Hub 4:25 1 year ago 125 Далее Скачать
What are the key differences between bispecific antibodies and CAR T cells? Multiple Myeloma Hub 3:03 3 years ago 147 Далее Скачать
Moving beyond CAR T-cell therapy: Why is everyone talking about NK-cell therapy? Multiple Myeloma Hub 1:56 3 years ago 191 Далее Скачать
What are the pros and cons of bispecific antibodies for multiple myeloma? Multiple Myeloma Hub 27:55 2 years ago 70 Далее Скачать
How to decide between bispecific antibodies or CAR T-cell therapies Multiple Myeloma Hub 8:31 4 years ago 283 Далее Скачать
CAR T-cell therapy for B-cell lymphomas: a focus on improving CR VJHemOnc – Video Journal of Hematology & HemOnc 3:04 5 years ago 173 Далее Скачать
Which classes of drugs are used for non-antibody based immunotherapies in MM? Multiple Myeloma Hub 3:06 5 years ago 70 Далее Скачать
How do I manage the risk of infection in patients treated with immunotherapies? Multiple Myeloma Hub 4:05 3 years ago 79 Далее Скачать
Analyzing Frontline Options for Patients With Bladder Cancer Targeted Oncology 1:56 6 years ago 146 Далее Скачать